MAP Pharma (MAPP) Misses Q4 Views by 2c

March 1, 2011 7:07 AM EST Send to a Friend
MAP Pharmaceuticals, Inc. (NASDAQ: MAPP) reported Q4 loss of $0.46, 2 cents worse than the analyst estimate of ($0.44).


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Add Your Comment